{"disease":{"id":"janus-kinase-inhibitors","name":"janus kinase inhibitors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06353087","title":"Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT06573593","title":"Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}